SCINAI IMMUNOTHERAPEUTICS LT (SCNI) Stock Price, Quote, News and Overview

What is the stock price of SCINAI IMMUNOTHERAPEUTICS LT today?

The current stock price of SCNI is 2.76 USD. The price decreased by -2.47% in the last trading session.

What is the ticker symbol for SCINAI IMMUNOTHERAPEUTICS LT stock?

The exchange symbol of SCINAI IMMUNOTHERAPEUTICS LT is SCNI and it is listed on the Nasdaq exchange.

On which exchange is SCNI stock listed?

SCNI stock is listed on the Nasdaq exchange.

What is the price forecast or stock price prediction for SCINAI IMMUNOTHERAPEUTICS LT stock?

7 analysts have analysed SCNI and the average price target is 714 USD. This implies a price increase of 25769.57% is expected in the next year compared to the current price of 2.76. Check the SCINAI IMMUNOTHERAPEUTICS LT stock analysts ratings, price target forecast and up-and down grades for more detailed information.

What is SCINAI IMMUNOTHERAPEUTICS LT worth?

SCINAI IMMUNOTHERAPEUTICS LT (SCNI) has a market capitalization of 2.58M USD. This makes SCNI a Nano Cap stock.

How many employees does SCINAI IMMUNOTHERAPEUTICS LT have?

SCINAI IMMUNOTHERAPEUTICS LT (SCNI) currently has 31 employees.

What are the support and resistance levels for SCINAI IMMUNOTHERAPEUTICS LT (SCNI) stock?

SCINAI IMMUNOTHERAPEUTICS LT (SCNI) has a support level at 2.75 and a resistance level at 2.79. Check the full technical report for a detailed analysis of SCNI support and resistance levels.

Should I buy SCINAI IMMUNOTHERAPEUTICS LT (SCNI) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:

• The Technical Analysis (TA) tab contains a technical analysis of SCNI, looking at technical quality and support and resistance levels
• The Fundamental Analysis (FA) tab contains a fundamental analysis of SCNI, evaluating the profitability, health, valuation and growth aspects
• SCINAI IMMUNOTHERAPEUTICS LT (SCNI) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
• SCINAI IMMUNOTHERAPEUTICS LT (SCNI) Sales and EPS estimates to see what analysts future expectations are.
• SCINAI IMMUNOTHERAPEUTICS LT (SCNI) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
• SCINAI IMMUNOTHERAPEUTICS LT (SCNI) Insider and Institutional Ownership to learn about the owners and their transactions.
• SCINAI IMMUNOTHERAPEUTICS LT (SCNI) Stock Chart to make your own analysis
• SCINAI IMMUNOTHERAPEUTICS LT (SCNI) Latest news and press-releases to stay up to date.

Does SCINAI IMMUNOTHERAPEUTICS LT (SCNI) stock pay dividends?

SCNI does not pay a dividend.

What is the Price/Earnings (PE) ratio of SCINAI IMMUNOTHERAPEUTICS LT (SCNI)?

SCINAI IMMUNOTHERAPEUTICS LT (SCNI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-18.7).

What is the Short Interest ratio of SCINAI IMMUNOTHERAPEUTICS LT (SCNI) stock?

The outstanding short interest for SCINAI IMMUNOTHERAPEUTICS LT (SCNI) is 0.68% of its float. Check the ownership tab for more information on the SCNI short interest.

ChartMill assigns a fundamental rating of 1 / 10 to SCNI. SCNI may be in some trouble as it scores bad on both profitability and health.

Over the last trailing twelve months SCNI reported a non-GAAP Earnings per Share(EPS) of -18.7. The EPS increased by 109% compared to the year before.

ChartMill assigns a Buy % Consensus number of 83% to SCNI. The Buy consensus is the average rating of analysts ratings from 7 analysts.